Related Experiment Video
Updated: Jul 2, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis
Huseyin Bozbas1, Aylin Yildirir, Ozlem Demir
1Baskent University, Faculty of Medicine, Department of Cardiology, Ankara, Turkey. hbozbas@gmail.com
Insights
Serum gamma-glutamyltransferase (GGT) is elevated in patients with calcific aortic stenosis (AS), indicating increased oxidative stress. This elevation appears more pronounced in advanced stages of calcific aortic valve disease.
Area of Science:
- Cardiology
- Biochemistry
- Oxidative Stress Research
Background:
- Serum gamma-glutamyltransferase (GGT) activity is linked to oxidative stress and cardiovascular diseases.
- Calcific aortic valve disease shares characteristics with atherosclerosis.
- The role of GGT in calcific aortic valve disease requires further investigation.
Purpose of the Study:
- To investigate the association between serum GGT activity and calcific aortic valve disease.
- To compare GGT levels in patients with aortic stenosis (AS) and aortic valve calcification (AVC) against controls.
Main Methods:
- Retrospective analysis of echocardiography data from 383 patients (AS, AVC, and controls).
- Serum GGT activity and other liver enzymes were measured and compared across groups.
- Age- and gender-matched controls with normal aortic valve morphology were selected.
Main Results:
- Serum GGT levels were significantly higher in AS patients compared to controls (median 23.0 U/L vs. 18.0 U/L).
- Patients with AVC did not show significantly different GGT levels compared to controls.
- Elevated C-reactive protein was also observed in AS patients.
Conclusions:
- Serum GGT activity is increased in patients with calcific aortic stenosis.
- Elevated GGT may indicate more advanced stages of calcific aortic valve disease.
Background And Aim Of The Study:
A growing body of data indicates an independent association between serum gamma-glutamyltransferase (GGT) activity, a marker of increased oxidative stress, and cardiovascular diseases. The process of calcific aortic valve disease has been shown to present characteristics of atherosclerosis. The study aim was to evaluate the possible role of serum GGT in patients with calcific aortic valve disease.
Methods:
The results of patients' echocardiography studies from 2005 for the presence of calcific aortic valve disease in the forms of aortic stenosis (AS) and aortic valve calcification (AVC) without significant valve stenosis, were retrospectively evaluated. Age-and gender-matched patients with normal aortic valve morphology were selected at random as a control group. A total of 383 patients was enrolled into the study (126 with AS, 133 with AVC, 124 controls). Serum GGT activity, along with other liver enzyme analyses and laboratory results, were determined and compared among the groups.
Results:
Age, gender and clinical and laboratory results were similar among the three groups. Median serum GGT levels in the AS, AVC and control groups were 23.0 U/1 (mean 31.5 +/- 24.9 U/1), 22.0 U/1 (mean 27.6 +/- 18.6 U/) and 18.0 U/l (mean 22.4 +/- 16.4 U/l), respectively. Compared to controls, AS patients had significantly higher serum GGT and C-reactive protein levels, while the differences between AVC patients and controls for these parameters were not significant.
Conclusion:
The study results suggest that serum GGT activity is increased in patients with calcific AS. These increases seem to occur in advanced rather than milder forms of calcific aortic valve disease.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Aortic Regurgitation III: Medical Management
